JEFFS ROGER 4
4 · Axsome Therapeutics, Inc. · Filed Aug 26, 2025
Insider Transaction Report
Form 4
JEFFS ROGER
Director
Transactions
- Sale
Common Stock
2025-08-26$120.03/sh−20,000$2,400,600→ 130,974 total - Sale
Common Stock
2025-08-22$120.08/sh−16,694$2,004,616→ 150,974 total
Footnotes (4)
- [F1]Represents the sale of underlying shares of previously exercised stock options.
- [F2]Such transaction was pursuant to a pre-approved 10b5-1 plan.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.00 and $120.34.
- [F4]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.00 and $120.26.